These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11227969)

  • 1. When should heparin preferably be administered during radiofrequency catheter ablation?
    Anfinsen OG; Gjesdal K; Aass H; Brosstad F; Orning OM; Amlie JP
    Pacing Clin Electrophysiol; 2001 Jan; 24(1):5-12. PubMed ID: 11227969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activation of platelet function, coagulation, and fibrinolysis during radiofrequency catheter ablation in heparinized patients.
    Anfinsen OG; Gjesdal K; Brosstad F; Orning OM; Aass H; Kongsgaard E; Amlie JP
    J Cardiovasc Electrophysiol; 1999 Apr; 10(4):503-12. PubMed ID: 10355691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial damage and activation of the hemostatic system during radiofrequency catheter isolation of pulmonary veins.
    Bulava A; Slavík L; Fiala M; Heinc P; Skvarilova M; Lukl J; Krcová V; Indrák K
    J Interv Card Electrophysiol; 2004 Jun; 10(3):271-9. PubMed ID: 15133367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of heparin on activation of platelet function in patients during radiofrequency catheter ablation.
    Wang LH; Jin ZM; Chen JZ; Zhu JH; Zheng LR; Tao QM; Zhang FR
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):66-70. PubMed ID: 16445701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation-fibrinolysis changes during off-pump bypass: effect of two heparin doses.
    Paparella D; Semeraro F; Scrascia G; Galeone A; Ammollo CT; Kounakis G; de Luca Tupputi Schinosa L; Semeraro N; Colucci M
    Ann Thorac Surg; 2010 Feb; 89(2):421-7. PubMed ID: 20103314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombogenicity of radiofrequency lesions: results with serial D-dimer determinations.
    Manolis AS; Melita-Manolis H; Vassilikos V; Maounis T; Chiladakis J; Christopoulou-Cokkinou V; Cokkinos DV
    J Am Coll Cardiol; 1996 Nov; 28(5):1257-61. PubMed ID: 8890824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment with antithrombotic agents during radiofrequency catheter ablation: a randomized comparison of aspirin versus ticlopidine.
    Manolis AS; Maounis T; Vassilikos V; Melita-Manolis H; Psarros L; Terzoglou G; Cokkinos DV
    J Cardiovasc Electrophysiol; 1998 Nov; 9(11):1144-51. PubMed ID: 9835257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does radiofrequency ablation induce a prethrombotic state? Analysis of coagulation system activation and comparison to electrophysiologic study.
    Dorbala S; Cohen AJ; Hutchinson LA; Menchavez-Tan E; Steinberg JS
    J Cardiovasc Electrophysiol; 1998 Nov; 9(11):1152-60. PubMed ID: 9835258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous hemostasis postcatheter ablation of atrial fibrillation while under therapeutic levels of oral and intravenous anticoagulation.
    Issa ZF; Amr BS
    J Interv Card Electrophysiol; 2015 Nov; 44(2):97-104. PubMed ID: 26223659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation intensity sufficient for haemodialysis does not prevent activation of coagulation and platelets.
    Sagedal S; Hartmann A; Sundstrøm K; Bjørnsen S; Brosstad F
    Nephrol Dial Transplant; 2001 May; 16(5):987-93. PubMed ID: 11328905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombogenicity of radiofrequency ablation procedures: what factors influence thrombin generation?
    Lee DS; Dorian P; Downar E; Burns M; Yeo EL; Gold WL; Paquette M; Lau W; Newman DM
    Europace; 2001 Jul; 3(3):195-200. PubMed ID: 11467460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anticoagulant effect of heparin during radiofrequency ablation (RFA) in patients taking apixaban or rivaroxaban.
    Brendel LC; Dobler F; Hessling G; Michel J; Braun SL; Steinsiek AL; Groha P; Eckl R; Deisenhofer I; Hyseni A; Roest M; Ott I; Steppich B
    J Interv Card Electrophysiol; 2017 Sep; 49(3):237-244. PubMed ID: 28735423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the concomitant use of heparin on the effects of warfarin during catheter ablation for atrial fibrillation.
    Inada K; Matsuo S; Tokutake K; Yokoyama K; Hioki M; Narui R; Ito K; Tanigawa S; Yamashita S; Tokuda M; Shibayama K; Miyanaga S; Sugimoto K; Yoshimura M; Yamane T
    Heart Vessels; 2016 Mar; 31(3):397-401. PubMed ID: 25471944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of hemostasis, endogenous fibrinolysis, platelet activation and endothelins after percutaneous transluminal coronary angioplasty in patients with stable angina.
    Borries M; Heins M; Fischer Y; Stiegler H; Peters A; Reinauer H; Schoebel FC; Strauer BE; Leschke M
    J Am Coll Cardiol; 1999 Aug; 34(2):486-93. PubMed ID: 10440163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study.
    Di Biase L; Gaita F; Toso E; Santangeli P; Mohanty P; Rutledge N; Yan X; Mohanty S; Trivedi C; Bai R; Price J; Horton R; Gallinghouse GJ; Beheiry S; Zagrodzky J; Canby R; Leclercq JF; Halimi F; Scaglione M; Cesarani F; Faletti R; Sanchez J; Burkhardt JD; Natale A
    Heart Rhythm; 2014 May; 11(5):791-8. PubMed ID: 24607716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of hemostatic activation created by right- and left-heart radiofrequency catheter ablation.
    Charng MJ; Lin YJ; Chiu TY; Cheng CM; Ding PY
    Clin Cardiol; 2004 Feb; 27(2):91-6. PubMed ID: 14979628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management.
    Koster A; Fischer T; Praus M; Haberzettl H; Kuebler WM; Hetzer R; Kuppe H
    Anesthesiology; 2002 Oct; 97(4):837-41. PubMed ID: 12357148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiologic procedures and activation of the hemostatic system.
    Michelucci A; Antonucci E; Conti AA; Alessandrello Liotta A; Fedi S; Padeletti L; Porciani MC; Prisco D; Abbate R; Gensini GF
    Am Heart J; 1999 Jul; 138(1 Pt 1):128-32. PubMed ID: 10385775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?
    Brinks HJ; Weerwind PW; Bogdan S; Verbruggen H; Brouwer MH
    Perfusion; 2001 Jan; 16(1):3-12. PubMed ID: 11192305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.